Patents – Just Ingredients

Patents

Schedule B – Licensed Patents
Schedule B

Licensed Patents

Title Registration No. Registration Date
Compositions and Methods for Producing Elevated and Sustained Dietary Ketosis 9138420 9/22/15
Compositions and Methods for Producing Elevated and Sustained Ketosis 9675577 6/13/17
Compositions and Methods for Producing Elevated and Sustained Ketosis 10646462 5/12/20
Mixed Salt Compositions for Production Elevated and Sustained Ketosis 10292952 5/21/19
Mixed Salt Compositions for Producing Elevated and Sustained Ketosis 10736861 8/11/20
Mixed Salt Compositions for Producing Elevated and Sustained Ketosis 11020362 6/1/21
R-Beta-Hydroxybutyrate, S-Beta-Hydroxybutyrate, and RS-Beta-Hydroxybutyrate Mixed Salt Compositions 10973786 4/13/21
Beta-Hydroxybutyrate Mixed Salt Compositions and Methods of Use - Track 1 11241403 2/8/22
Beta-Hydroxybutyrate Mixed Salt Compositions and Methods of Use 11896565 2/13/24
Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the R-Enantiomer and Methods of Use- TRACK 1 10245242 4/2/19
Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the R-Enantiomer and Methods of Use 10588876 3/17/20
Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the R-Enantiomer and Methods of Use 10596129 3/24/20
Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the R-Enantiomer and Methods of Use 10596131 3/24/20
Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the R-Enantiomer and Methods of Use 11103470 8/31/21
Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the R-Enantiomer and Methods of Use 11690817 7/4/23
Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the S-Enantiomer and Methods of Use- TRACK 1 10245243 4/2/19
Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the S-Enantiomer and Methods of Use 10596128 3/24/20
Non-Racemic Beta-Hydroxybutyrate Compounds and Compositions Enriched with the S-Enantiomer and Methods of Use 10596130 3/24/20
S-Beta-Hydroxybutyrate Compounds and Compositions Enriched with S-Enantiomer 11185518 11/30/21
Compositions Containing S-Beta-Hydroxybutyrate or Non-Racemic Mixtures Enriched with S-Enantiomer 11944598 4/2/24
Racemic Beta-Hydroxybutyrate Compositions and Methods of Use 10973792 4/13/21
Racemic and Near Racemic Beta-Hydroxybutyrate Compositions 11419836 8/23/22
Enantiomerically Pure R-Beta-Hydroxybutyrate Mixed Salt-Acid Compositions 11241401 2/8/22
Beta-Hydroxybutyric Acid Compositions and Methods for Oral Delivery of Ketone Bodies 11806324 11/7/23
Administration of Butyrate, Beta-Hydroxybutyrate, and Related Compounds in Humans 11173138 11/16/21
Administration of Berberine Metabolites 11026929 6/8/21
Administration of Berberine Metabolites 11969411 4/30/24
Administration of Beta-Hydroxybutyrate and Related Compounds in Humans for the Treatment and/or Prevention of Respiratory Illnesses 11752119 9/12/23